AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27

Authors: Wernyj, RP Ewing, CM Isaacs, WB
Citation: Rp. Wernyj et al., Multiple Antibodies to Titin Immunoreact With AHNAK and Localize to the Mitotic Spindle Machinery, CELL MOTIL, 50(2), 2001, pp. 101-113

Authors: Zheng, SL Xu, JF Isaacs, SD Wiley, K Chang, BL Bleecker, ER Walsh, PC Trent, JM Meyers, DA Isaacs, WB
Citation: Sl. Zheng et al., Evidence for a prostate cancer linkage to chromosome 20 in 159 hereditary prostate cancer families, HUM GENET, 108(5), 2001, pp. 430-435

Authors: Xu, JF Zheng, SL Chang, BL Smith, JR Carpten, JD Stine, OC Isaacs, SD Wiley, KE Henning, L Ewing, C Bujnovszky, P Bleeker, ER Walsh, PC Trent, JM Meyers, DA Isaacs, WB
Citation: Jf. Xu et al., Linkage of prostate cancer susceptibility loci to chromosome 1, HUM GENET, 108(4), 2001, pp. 335-345

Authors: Kibel, AS Christopher, M Faith, DA Bova, GS Goodfellow, PJ Isaacs, WB
Citation: As. Kibel et al., Methylation and mutational analysis of p27(kipl) in prostate carcinoma, PROSTATE, 48(4), 2001, pp. 248-253

Authors: Isaacs, JT Bartsch, G Isaacs, WB
Citation: Jt. Isaacs et al., From the editorial office, PROSTATE, 48(3), 2001, pp. 127-127

Authors: Hsing, AW Chang, L Nomura, AM Isaacs, WB Armenian, HK
Citation: Aw. Hsing et al., A glimpse into the future, EPIDEMIOL R, 23(1), 2001, pp. 2-2

Authors: Chang, BL Zheng, SQL Isaacs, SD Wiley, KE Carpten, JD Hawkins, GA Bleecker, ER Walsh, PC Trent, JM Meyers, DA Isaacs, WB Xu, JF
Citation: Bl. Chang et al., Linkage and association of CYP17 gene in hereditary and sporadic prostate cancer, INT J CANC, 95(6), 2001, pp. 354-359

Authors: Yasunaga, Y Nakamura, K Ewing, CM Isaacs, WB Hukku, B Rhim, JS
Citation: Y. Yasunaga et al., A novel human cell culture model for the study of familial prostate cancer, CANCER RES, 61(16), 2001, pp. 5969-5973

Authors: Luo, J Duggan, DJ Chen, YD Sauvageot, J Ewing, CM Bittner, ML Trent, JM Isaacs, WB
Citation: J. Luo et al., Human prostate cancer and benign prostatic hyperplasia: Molecular dissection by gene expression profiling, CANCER RES, 61(12), 2001, pp. 4683-4688

Authors: Nelson, CP Kidd, LCR Sauvageot, J Isaacs, WB De Marzo, AM Groopman, JD Nelson, WG Kensler, TW
Citation: Cp. Nelson et al., Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1, CANCER RES, 61(1), 2001, pp. 103-109

Authors: Lin, XH Tascilar, M Lee, WH Vles, WJ Lee, BH Veeraswamy, R Asgari, K Freije, D van Rees, B Gage, WR Bova, GS Isaacs, WB Brooks, JD DeWeese, TL De Marzo, AM Nelson, WG
Citation: Xh. Lin et al., GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells, AM J PATH, 159(5), 2001, pp. 1815-1826

Authors: Xu, JF Zheng, SQL Hawkins, GA Faith, DA Kelly, B Isaacs, SD Wiley, KE Chang, BL Ewing, CM Bujnovszky, P Carpten, JD Bleecker, ER Walsh, PC Trent, JM Meyers, DA Isaacs, WB
Citation: Jf. Xu et al., Linkage and association studies of prostate cancer susceptibility: Evidence for linkage at 8p22-23, AM J HU GEN, 69(2), 2001, pp. 341-350

Authors: Xu, JF Zheng, SQL Carpten, JD Nupponen, NN Robbins, CM Mestre, J Moses, TY Faith, DA Kelly, BD Isaacs, SD Wiley, KE Ewing, DM Bujnowszky, P Chang, BI Bailey-Wilson, J Bleecker, ER Walsh, PC Trent, JM Meyers, DA Isaacs, WB
Citation: Jf. Xu et al., Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer, AM J HU GEN, 68(4), 2001, pp. 901-911

Authors: Isaacs, WB Xu, JF Walsh, PC
Citation: Wb. Isaacs et al., Hereditary prostate cancer, CONT CANC R, 2001, pp. 13-28

Authors: Shepard, TF Platz, EA Kantoff, PW Nelson, WG Isaacs, WB Freije, D Febbo, PG Stampfer, MJ Giovannucci, E
Citation: Tf. Shepard et al., No association between the I105V polymorphism of the glutathione S-transferase P1 gene (GSTP1) and prostate cancer risk: A prospective study, CANC EPID B, 9(11), 2000, pp. 1267-1268

Authors: Tchou, JC Lin, XH Freije, D Isaacs, WB Brooks, JD Rashid, A De Marzo, AM Kanai, Y Hirohashi, S Nelson, WG
Citation: Jc. Tchou et al., GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas, INT J ONCOL, 16(4), 2000, pp. 663-676

Authors: Chesire, DR Ewing, CM Sauvageot, J Bova, GS Isaacs, WB
Citation: Dr. Chesire et al., Detection and analysis of beta-catenin mutations in prostate cancer, PROSTATE, 45(4), 2000, pp. 323-334

Authors: Kibel, AS Isaacs, WB
Citation: As. Kibel et Wb. Isaacs, G(1)/S cell cycle proteins as markers of aggressive prostate carcinoma, UROLOGY, 55(3), 2000, pp. 316-322

Authors: Kibel, AS Faith, DA Bova, GS Isaacs, WB
Citation: As. Kibel et al., Loss of heterozygosity at 12P12-13 in primary and metastatic prostate adenocarcinoma, J UROL, 164(1), 2000, pp. 192-196

Authors: Brooks, JD Marshall, FF Isaacs, WB Johns, DR
Citation: Jd. Brooks et al., Absence of HinfI restriction abnormalities in renal oncocytoma mitochondrial DNA, MOL UROL, 3(1), 1999, pp. 1-3

Authors: Kibel, AS Freije, D Isaacs, WB Bova, GS
Citation: As. Kibel et al., Deletion mapping at 12p12-13 in metastatic prostate cancer, GENE CHROM, 25(3), 1999, pp. 270-276

Authors: Wilkens, EP Freije, D Xu, JF Nusskern, DR Suzuki, H Isaacs, SD Wiley, K Bujnovszky, P Meyers, DA Walsh, PC Isaacs, WB
Citation: Ep. Wilkens et al., No evidence for a role of BRCA1 or BRCA2 mutations in Ashkenazi Jewish families with hereditary prostate cancer, PROSTATE, 39(4), 1999, pp. 280-284

Authors: Zhong, H De Marzo, AM Laughner, E Lim, M Hilton, DA Zagzag, D Buechler, P Isaacs, WB Semenza, GL Simons, JW
Citation: H. Zhong et al., Overexpression of hypoxia-inducible factor 1 alpha in common human cancersand their metastases, CANCER RES, 59(22), 1999, pp. 5830-5835

Authors: Lou, W Krill, D Dhir, R Becich, MJ Dong, JT Frierson, HF Isaacs, WB Isaacs, JT Gao, AC
Citation: W. Lou et al., Methylation of the CD44 metastasis suppressor gene in human prostate cancer, CANCER RES, 59(10), 1999, pp. 2329-2331

Authors: Kibel, AS Schutte, M Kern, SE Isaacs, WB Bova, GS
Citation: As. Kibel et al., Identification of 12p as a region of frequent deletion in advanced prostate cancer, CANCER RES, 58(24), 1998, pp. 5652-5655
Risultati: 1-25 | 26-27